Crédit Industriel et Commercial’s Astria Therapeutics ATXS Stock Holding History

Crédit Industriel et Commercial’s Portfolio ATXS Stock Details ATXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-100,000	Closed	-$1.31M	–	360
2025 Q4	$1.31M	Buy	+100,000	New	+$1.19M	0.1%	206

Crédit Industriel et Commercial's ATXS Position: Q1 2026 in Review

Crédit Industriel et Commercial sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 100,000 shares — an estimated $1.31M sold.

Crédit Industriel et Commercial first reported a position in ATXS in Q4 2025 and held it in 1 quarter. The position peaked at $1.31M in Q4 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

Crédit Industriel et Commercial reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
Crédit Industriel et Commercial sold 100,000 Astria Therapeutics shares in Q1 2026, an estimated $1.31M.
Crédit Industriel et Commercial first reported a position in Astria Therapeutics in Q4 2025 and held it in 1 quarter.
Crédit Industriel et Commercial's Astria Therapeutics position peaked at $1.31M in Q4 2025.
0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on Crédit Industriel et Commercial's 13F filing for Q1 2026, filed 29 Apr 2026.